Detalhe da pesquisa
1.
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
Blood
; 137(7): 896-907, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32976576
2.
Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.
Biol Blood Marrow Transplant
; 26(1): 94-106, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493539
3.
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.
Blood
; 130(19): 2131-2145, 2017 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28851699
4.
T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.
Blood
; 128(13): 1688-700, 2016 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27412889
5.
Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo.
Stem Cells
; 33(4): 1200-12, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25532725
6.
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 21(6): 1083-90, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25771402
7.
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.
Blood
; 122(25): 4129-39, 2013 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24055823
8.
Successful Bone Marrow Transplantation for XMEN: Hemorrhagic Risk Uncovered.
J Clin Immunol
; 39(1): 1-3, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30470981
9.
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.
Blood
; 119(12): 2956-9, 2012 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22289893
10.
Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease.
JID Innov
; 4(2): 100246, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357212
11.
Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.
JCI Insight
; 8(11)2023 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129971
12.
Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease.
iScience
; 25(1): 103592, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35005541
13.
HIV-1 Nef binds a subpopulation of MHC-I throughout its trafficking itinerary and down-regulates MHC-I by perturbing both anterograde and retrograde trafficking.
J Biol Chem
; 285(40): 30884-905, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20622010
14.
Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.
Bone Marrow Transplant
; 56(12): 2934-2939, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433916
15.
Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Nat Med
; 26(5): 803, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32291416
16.
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Nat Med
; 26(2): 270-280, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959992
17.
Cholesterol is obligatory for polarization and chemotaxis but not for endocytosis and associated signaling from chemoattractant receptors in human neutrophils.
J Biomed Sci
; 15(4): 441-61, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18311596
18.
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.
J Clin Oncol
; 36(22): 2267-2280, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29812997
19.
Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4.
Mol Biol Cell
; 14(8): 3305-24, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12925765
20.
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.
J Clin Oncol
; 34(10): 1112-21, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26811520